Man Group PLC Sangamo Therapeutics, Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $15,624 - $39,600	-26,939 Reduced 17.07%	130,911 $78,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $65,521 - $102,708	59,028 Added 59.73%	157,850 $205,000
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $76,223 - $168,519	-45,918 Reduced 31.72%	98,822 $173,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $290,298 - $531,341	104,801 Added 262.4%	144,740 $454,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $170,539 - $255,210	39,939 New	39,939 $196,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $1.47 Million - $2.3 Million	-135,166 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $177,982 - $350,564	-19,283 Reduced 12.49%	135,166 $2.11 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $218,647 - $290,908	23,310 Added 17.78%	154,449 $1.46 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $466,929 - $889,497	75,190 Added 134.39%	131,139 $1.18 Million
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $85,850 - $150,450	17,000 Added 43.65%	55,949 $356,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $632,133 - $853,554	-69,849 Reduced 64.2%	38,949 $352,000
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $52,500 - $78,180	6,000 Added 5.84%	108,798 $1.17 Million
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $258,774 - $429,391	33,520 Added 48.38%	102,798 $981,000
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $703,492 - $1.23 Million	-73,974 Reduced 51.64%	69,278 $795,000
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $2,088 - $3,048	160 Added 0.11%	143,252 $2.43 Million
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $1.19 Million - $1.7 Million	85,900 Added 150.2%	143,092 $2.03 Million
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $955,106 - $1.51 Million	57,192 New	57,192 $1.09 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account